Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.

Journal Article (Clinical Trial, Phase III;Letter)

Full Text

Duke Authors

Cited Authors

  • Walter, RB; Michaelis, LC; Othus, M; Uy, GL; Radich, JP; Little, RF; Hita, S; Saini, L; Foran, JM; Gerds, AT; Klepin, HD; Hay, AE; Assouline, S; Lancet, JE; Couban, S; Litzow, MR; Stone, RM; Erba, HP

Published Date

  • February 2018

Published In

Volume / Issue

  • 93 / 2

Start / End Page

  • E49 - E52

PubMed ID

  • 29164656

Pubmed Central ID

  • 29164656

Electronic International Standard Serial Number (EISSN)

  • 1096-8652

Digital Object Identifier (DOI)

  • 10.1002/ajh.24980

Language

  • eng

Conference Location

  • United States